- Home
- HBNC vs IMNM Comparison
HBNC vs IMNM Comparison
Compare HBNC & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- IMNM
- Stock Information
- Founded
- HBNC 1873
- IMNM 2006
- Country
- HBNC United States
- IMNM United States
- Employees
- HBNC N/A
- IMNM N/A
- Industry
- HBNC Major Banks
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- HBNC Finance
- IMNM Health Care
- Exchange
- HBNC Nasdaq
- IMNM Nasdaq
- Market Cap
- HBNC 654.4M
- IMNM 748.3M
- IPO Year
- HBNC N/A
- IMNM 2020
- Fundamental
- Price
- HBNC $14.60
- IMNM $8.75
- Analyst Decision
- HBNC Hold
- IMNM Strong Buy
- Analyst Count
- HBNC 2
- IMNM 5
- Target Price
- HBNC $17.00
- IMNM $26.40
- AVG Volume (30 Days)
- HBNC 158.6K
- IMNM 874.4K
- Earning Date
- HBNC 07-23-2025
- IMNM 08-11-2025
- Dividend Yield
- HBNC 4.38%
- IMNM N/A
- EPS Growth
- HBNC 88.54
- IMNM N/A
- EPS
- HBNC 1.02
- IMNM N/A
- Revenue
- HBNC $201,164,000.00
- IMNM $10,938,000.00
- Revenue This Year
- HBNC $46.44
- IMNM N/A
- Revenue Next Year
- HBNC $4.83
- IMNM $349.38
- P/E Ratio
- HBNC $14.32
- IMNM N/A
- Revenue Growth
- HBNC 11.46
- IMNM N/A
- 52 Week Low
- HBNC $11.52
- IMNM $5.15
- 52 Week High
- HBNC $19.18
- IMNM $16.81
- Technical
- Relative Strength Index (RSI)
- HBNC 44.62
- IMNM 48.43
- Support Level
- HBNC $14.34
- IMNM $9.02
- Resistance Level
- HBNC $15.35
- IMNM $9.91
- Average True Range (ATR)
- HBNC 0.36
- IMNM 0.55
- MACD
- HBNC -0.06
- IMNM -0.08
- Stochastic Oscillator
- HBNC 25.74
- IMNM 9.37
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.